![Martin Abend](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Abend
Presidente presso Rechtsanwaltskammer Sachsen
Profilo
Martin Abend is currently the President & Director at Rechtsanwaltskammer Sachsen since 2013.
He is also the Vice President at Bundesrechtsanwaltskammer since 2013.
Previously, he served as the Chairman-Supervisory Board at STADA Arzneimittel AG from 2009 to 2016.
Dr. Abend holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Posizioni attive di Martin Abend
Società | Posizione | Inizio |
---|---|---|
Rechtsanwaltskammer Sachsen | Presidente | 01/01/1999 |
Bundesrechtsanwaltskammer | Corporate Officer/Principal | 01/01/1996 |
Precedenti posizioni note di Martin Abend
Società | Posizione | Fine |
---|---|---|
STADA ARZNEIMITTEL | Presidente | 26/08/2016 |
Formazione di Martin Abend
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
STADA Arzneimittel AG
![]() STADA Arzneimittel AG Pharmaceuticals: MajorHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Rechtsanwaltskammer Sachsen | |
Bundesrechtsanwaltskammer |
- Borsa valori
- Insiders
- Martin Abend